{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:26:11Z","timestamp":1761895571941},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,11,18]],"date-time":"2012-11-18T00:00:00Z","timestamp":1353196800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s12020-012-9832-7","type":"journal-article","created":{"date-parts":[[2012,11,17]],"date-time":"2012-11-17T00:13:35Z","timestamp":1353111215000},"page":"535-538","source":"Crossref","is-referenced-by-count":9,"title":["Hormonal male contraception: end of a dream or start of a new era?"],"prefix":"10.1007","volume":"43","author":[{"given":"Eberhard","family":"Nieschlag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,18]]},"reference":[{"key":"9832_CR1","unstructured":"A. Brodmerkel, Schonfrist f\u00fcr Spermien. Frankfurter Rundschau, 27 Sep 2012, p. 23 (2012)"},{"key":"9832_CR2","unstructured":"D.J. Patanelli, Hormonal control of male infertility. Bethesda US Department of Health, Education and Welfare. National Institutes of Health. Publication No. (NIH) 1978; 78, 1097 (1978)"},{"key":"9832_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(03)00577-6","volume":"80","author":"GMH Waites","year":"2003","unstructured":"G.M.H. Waites, Developments of methods of male contraception: impact of the World Health Organisation Task Force. Fertil. Steril. 80, 1\u201315 (2003)","journal-title":"Fertil. Steril."},{"key":"9832_CR4","doi-asserted-by":"crossref","unstructured":"E. Nieschlag, R. Sitruk-Ware, N. Kumar, 7\u03b1-Methyl-19-nortestosterone (MENTR): the Population Council\u2019s contribution to research on male contraception and treatment of hypogonadism. Contraception (2012). doi: 10.1016\/j.contraception.2012.08.036","DOI":"10.1016\/j.contraception.2012.08.036"},{"key":"9832_CR5","first-page":"1","volume":"2","author":"NR Farnsworth","year":"1982","unstructured":"N.R. Farnsworth, D.P. Waller, Current status of plant products reported to inhibit sperm. Res. Front. Fertil. Regul. 2, 1\u201316 (1982)","journal-title":"Res. Front. Fertil. Regul."},{"key":"9832_CR6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/978-3-540-78355-8_30","volume-title":"Andrology: Male Reproductive Health and Dysfunction","author":"TG Cooper","year":"2010","unstructured":"T.G. Cooper, C.H. Yeung, Pharmacological approaches to male contraception, in Andrology: Male Reproductive Health and Dysfunction, 3rd edn., ed. by E. Nieschlag, H.M. Behre, S. Nieschlag (Springer, Heidelberg, 2010), pp. 589\u2013599","edition":"3"},{"key":"9832_CR7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1017\/CBO9781139003353","volume-title":"Testosterone: Action, Deficiency, Substitution","author":"E Nieschlag","year":"2012","unstructured":"E. Nieschlag, H.M. Behre, The essential role of testosterone in hormonal male contraception, in Testosterone: Action, Deficiency, Substitution, 4th edn., ed. by E. Nieschlag, H.M. Behre (Cambridge University Press, Cambridge, 2012), pp. 479\u2013539","edition":"4"},{"key":"9832_CR8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.contraception.2010.03.020","volume":"82","author":"E Nieschlag","year":"2010","unstructured":"E. Nieschlag, Clinical trials in male hormonal contraception (review). Contraception 82, 457\u2013470 (2010)","journal-title":"Contraception"},{"key":"9832_CR9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0010-7824(79)90084-2","volume":"20","author":"A Barfield","year":"1979","unstructured":"A. Barfield, J. Melo, E. Coutinho et al., Pregnancies associated with sperm concentrations below 10 million\/ml in clinical studies of a potential male contraceptive method, monthly depot medroxyprogesterone acetate and testosterone esters. Contraception 20, 121\u2013127 (1979)","journal-title":"Contraception"},{"key":"9832_CR10","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0140-6736(90)92416-F","volume":"336","author":"World Health Organization Task Force on Methods for the Regulation of Male Fertility","year":"1990","unstructured":"World Health Organization Task Force on Methods for the Regulation of Male Fertility, Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 336, 955\u2013959 (1990)","journal-title":"Lancet"},{"key":"9832_CR11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0015-0282(16)58221-1","volume":"65","author":"World Health Organization Task Force on Methods for the Regulation of Male Fertility","year":"1996","unstructured":"World Health Organization Task Force on Methods for the Regulation of Male Fertility, Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil. Steril. 65, 821\u2013829 (1996)","journal-title":"Fertil. Steril."},{"key":"9832_CR12","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1210\/jc.2002-020447","volume":"88","author":"Y-Q Gu","year":"2003","unstructured":"Y.-Q. Gu, X.-H. Wang, D. Xu et al., A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men. J. Clin. Endocrinol. Metab. 88, 562\u2013568 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9832_CR13","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1210\/jc.2008-1846","volume":"94","author":"Y Gu","year":"2009","unstructured":"Y. Gu, X. Liang, W. Wu et al., Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men. J. Clin. Endocrinol. Metab. 94, 1910\u20131915 (2009)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9832_CR14","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/humrep\/der138","volume":"26","author":"JC Soufir","year":"2011","unstructured":"J.C. Soufir, G. Meduri, A. Ziyyat, Spermatogenetic inhibition in men taking a combination of oral medroxyprogesterone acetate and percutaneous testosterone as a male contraceptive method. Hum. Reprod. 26, 1708\u20131714 (2011)","journal-title":"Hum. Reprod."},{"key":"9832_CR15","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1210\/jc.2003-030107","volume":"88","author":"L Turner","year":"2003","unstructured":"L. Turner, A.J. Conway, M. Jiminez et al., Contraceptive efficacy of a depot gestagen and androgen combination in men. J. Clin. Endocrinol. Metab. 88, 4659\u20134667 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9832_CR16","unstructured":"WHO, Controlled trials register NET-EN plus TU as a male contraceptive. (WHO-HRP ID A25165, 2005). http:\/\/www.who.int\/reproductive-health\/rhl\/a25165.html"},{"key":"9832_CR17","unstructured":"WHO Laboratory Manual for the Examination and Processing of Human Sperm, 5th edn. (WHO, Geneva, 2010)"},{"key":"9832_CR18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.fertnstert.2012.05.006","volume":"98","author":"C Mallidis","year":"2012","unstructured":"C. Mallidis, T.G. Cooper, B. Hellenkemper, M. Lablans, F. \u00dcckert, E. Nieschlag, Ten years experience with an external quality control programme for semen analysis. Fertil. Steril. 98, 611\u2013616 (2012)","journal-title":"Fertil. Steril."},{"key":"9832_CR19","doi-asserted-by":"crossref","first-page":"144\u2013152","DOI":"10.1046\/j.1365-2605.1997.00045.x","volume":"20","author":"B Lemcke","year":"1997","unstructured":"B. Lemcke, H.M. Behre, E. Nieschlag, Frequently subnormal semen profiles of normal volunteers recruited over 17\u00a0years. Int. J. Androl. 20, 144\u2013152 (1997)","journal-title":"Int. J. Androl."},{"key":"9832_CR20","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-2605.2011.01142.x","volume":"34","author":"E Nieschlag","year":"2011","unstructured":"E. Nieschlag, E. Vorona, M. Wenk, A.K. Hemker, A. Kamischke, M. Zitzmann, Hormonal male contraception in men with normal and subnormal semen parameters. Int. J. Androl. 34, 556\u2013567 (2011)","journal-title":"Int. J. Androl."},{"key":"9832_CR21","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(06)68614-5","volume":"367","author":"PY Liu","year":"2006","unstructured":"P.Y. Liu, R.S. Swerdloff, P.D. Christenson, D.J. Handelsman, C. Wang, Hormonal Male Contraception Summit Group: rate, extent and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet 367, 1412\u20131420 (2006)","journal-title":"Lancet"},{"key":"9832_CR22","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1210\/jc.2007-2768","volume":"93","author":"PY Liu","year":"2008","unstructured":"P.Y. Liu, R.S. Swerdloff, B.D. Anawalt, R.A. Anderson, W.J. Bremner, J. Elliesen, Y.Q. Gu, W.M. Kersemaekers, R.I. McLachlan, M.C. Meriggiola, E. Nieschlag, R. Sitruk-Ware, K. Vogelsong, X.H. Wang, F.C. Wu, M. Zitzmann, D.J. Handelsman, C. Wang, Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis. J. Clin. Endocrinol. Metab. 93, 1774\u20131783 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9832_CR23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/humrep\/deh574","volume":"20","author":"K Heinemann","year":"2005","unstructured":"K. Heinemann, F. Saad, M. Wiesemes, S. White, L. Heinemann, Attitudes toward male fertility control: results of a multinational survey on four continents. Hum. Reprod. 20, 549\u2013556 (2005)","journal-title":"Hum. Reprod."},{"key":"9832_CR24","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1210\/jc.2002-022043","volume":"88","author":"S Eckardstein von","year":"2003","unstructured":"S. von Eckardstein, G. Noe, V. Brache et al., International Committee for Contraception Research, The Population Council: a clinical trial of 7alpha-methyl-19-nortestosterone implants for possible use as a longacting contraceptive for men. J. Clin. Endocrinol. Metab. 88, 5232\u20135239 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9832_CR25","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1210\/jc.2012-1384","volume":"97","author":"N Ilani","year":"2012","unstructured":"N. Ilani, M.Y. Roth, J.K. Amory, R.S. Swerdloff, C. Dart, S.T. Page, W.J. Bremner, R. Sitruk-Ware, N. Kumar, D.L. Blithe, C. Wang, A new combination of testosterone and nestorone transdermal gels for male hormonal contraception. J. Clin. Endocrinol. Metab. 97, 3476\u20133486 (2012). doi: 10.1210\/jc.2012-1384","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9832_CR26","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1210\/jc.2008-0265","volume":"93","author":"E Mommers","year":"2008","unstructured":"E. Mommers, W.M. Kersemaekers, J. Elliesen et al., Male hormonal contraception: a double-blind, placebo-controlled study. J. Clin. Endocrinol. Metab. 93, 2572\u20132580 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9832_CR27","unstructured":"http:\/\/conrad.org\/contraception-trials.html (2012). Accessed 21 Sep 2012"},{"key":"9832_CR28","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1210\/jc.87.2.530","volume":"87","author":"A Kamischke","year":"2002","unstructured":"A. Kamischke, T. Heuermann, K. Kr\u00fcger et al., An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations. J. Clin. Endocrinol. Metab. 87, 530\u2013539 (2002)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9832_CR29","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1210\/jc.2004-1852","volume":"90","author":"MC Meriggiola","year":"2005","unstructured":"M.C. Meriggiola, A. Costantino, F. Saad et al., Norethisterone enanthate plus testosterone undecanoate for male contraception: effects of various injection intervals on spermatogenesis, reproductive hormones, testis, and prostate. J. Clin. Endocrinol. Metab. 90, 2005\u20132014 (2005)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9832_CR30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13625180601012311","volume":"12","author":"G Benagiano","year":"2007","unstructured":"G. Benagiano, C. Bastianelli, M. Farris, Contraception: a social revolution. Eur. J. Contracept. Reprod. Health Care. 12, 3\u201312 (2007)","journal-title":"Eur. J. Contracept. Reprod. Health Care."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-012-9832-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-012-9832-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-012-9832-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T18:34:59Z","timestamp":1562351699000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-012-9832-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,18]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["9832"],"URL":"https:\/\/doi.org\/10.1007\/s12020-012-9832-7","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,18]]}}}